These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20648612

  • 1. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A, Magri MC, Manuel RC.
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [Abstract] [Full Text] [Related]

  • 2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B.
    Virology; 1999 Apr 10; 256(2):381-92. PubMed ID: 10191203
    [Abstract] [Full Text] [Related]

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA, Pierrotti LC, Sumita LM, Freire WS, Segurado AA, Pannuti CS.
    J Med Virol; 2007 Oct 10; 79(10):1562-8. PubMed ID: 17705173
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC, Carbone PH, de los Santos-Fortuna E, Caterino-de-Araujo A.
    J Med Virol; 2009 Jul 10; 81(7):1292-7. PubMed ID: 19475629
    [Abstract] [Full Text] [Related]

  • 5. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E.
    Virology; 1998 Mar 30; 243(1):208-17. PubMed ID: 9527930
    [Abstract] [Full Text] [Related]

  • 6. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Söderström T, Wadström J, Linde A.
    J Med Virol; 2000 Dec 30; 62(4):498-504. PubMed ID: 11074479
    [Abstract] [Full Text] [Related]

  • 7. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
    Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ.
    J Infect Dis; 2003 Jan 01; 187(1):12-8. PubMed ID: 12508141
    [Abstract] [Full Text] [Related]

  • 8. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N, Spira T, Lam L, Corchero JL, Luo W.
    J Med Virol; 2004 Oct 01; 74(2):202-6. PubMed ID: 15332267
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM, Newton R, Urban MI, Stein L, Hale M, Patel M, Ruff P, Sur R, Bourboulia D, Sitas F.
    BMC Infect Dis; 2003 Sep 12; 3():21. PubMed ID: 12971827
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: potential for endemic and epidemic Kaposi's sarcoma.
    Caterino-de-Araujo A, Manuel RC, Del Bianco R, Santos-Fortuna E, Magri MC, Silva JM, Bastos R.
    J Med Virol; 2010 Jul 12; 82(7):1216-23. PubMed ID: 20513087
    [Abstract] [Full Text] [Related]

  • 11. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore PS.
    N Engl J Med; 1996 Jul 25; 335(4):233-41. PubMed ID: 8657239
    [Abstract] [Full Text] [Related]

  • 12. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.
    Martro E, Bulterys M, Stewart JA, Spira TJ, Cannon MJ, Thacher TD, Bruns R, Pellett PE, Dollard SC.
    J Med Virol; 2004 Jan 25; 72(1):126-31. PubMed ID: 14635020
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
    Szalai E, Gerlei Z, Szlávik J, Szládek G, Patel R, Hunyadi J, Gergely L, Juhász A.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):265-8. PubMed ID: 15681157
    [Abstract] [Full Text] [Related]

  • 14. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
    Katano H, Sato Y, Kurata T, Mori S, Sata T.
    Virology; 2000 Apr 10; 269(2):335-44. PubMed ID: 10753712
    [Abstract] [Full Text] [Related]

  • 15. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S, Bellan C, Amato T, Palummo N, Cardone C, D'Amuri A, De Luca F, Beyanga M, Facchetti F, Tosi P, Leoncini L.
    Hum Pathol; 2006 Jan 10; 37(1):23-31. PubMed ID: 16360412
    [Abstract] [Full Text] [Related]

  • 16. Sexual transmission and the natural history of human herpesvirus 8 infection.
    Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH.
    N Engl J Med; 1998 Apr 02; 338(14):948-54. PubMed ID: 9521982
    [Abstract] [Full Text] [Related]

  • 17. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.
    Plancoulaine S, Abel L, Trégouët D, Duprez R, van Beveren M, Tortevoye P, Froment A, Gessain A.
    Cancer Res; 2004 Dec 01; 64(23):8782-7. PubMed ID: 15574792
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
    Okroj M, Tedeschi R, Mancuso R, Brambilla L, Tourlaki A, Dillner J, Blom AM.
    Vaccine; 2011 Feb 01; 29(6):1129-34. PubMed ID: 21134448
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET, Blackbourn DJ, Levy JA.
    Lancet; 1996 Sep 28; 348(9031):858-61. PubMed ID: 8826812
    [Abstract] [Full Text] [Related]

  • 20. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
    Tanzi E, Zappa A, Caramaschi F, Amendola A, Lasagna D, Gatti L, Ascoli V, Rezza G, Zanetti AR.
    J Med Virol; 2005 Aug 28; 76(4):571-5. PubMed ID: 15977229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.